Redhill Biopharma
RDHL
#10476
Rank
NZ$6.85 M
Marketcap
NZ$2.06
Share price
-0.83%
Change (1 day)
-83.91%
Change (1 year)

Revenue for Redhill Biopharma (RDHL)

Revenue in 2022: NZ$97.33 Million

According to Redhill Biopharma's latest financial reports the company's current revenue (TTM ) is NZ$61.83 Million. In 2022 the company made a revenue of NZ$97.33 Million a decrease over the revenue in the year 2021 that were of NZ$0.12 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Redhill Biopharma from 2012 to 2022

Annual revenue

Year Revenue Change
2022NZ$97.33 M-22.47%
2021NZ$0.12 B40.76%
2020NZ$89.19 M854.89%
2019NZ$9.34 M-25.05%
2018NZ$12.46 M120.9%
2017NZ$5.64 M3769.49%
2016NZ$0.14 M3226.46%
2015NZ$0 M-99.95%
2014NZ$8.95 M61203.09%
2013NZ$0.01 M-24.92%
2012NZ$0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sanofi
SNY
NZ$82.20 B 132,855.88%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$111.11 B 179,603.46%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$73.26 B 118,385.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Taro Pharmaceutical
TARO
NZ$1.05 B 1,608.85%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Teva Pharmaceutical Industries
TEVA
NZ$29.01 B 46,832.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel